Wednesday, April 27, 2022 7:14:47 PM
20-24 patients dosed.
Day 57 scans from 14-18 patients.
Up to 10 patients on schedule B3 (TIL-like).
Day 113 scans from 9-11 patients.
Up to 8 patients on schedule B3 (TIL-like).
Tumour mix: NSCLC, SCCHN, UC, and melanoma likely to predominate.
Biomarker data: ctDNA, tumour infiltration, TCR sequencing and proliferation and persistence.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM